SCHEMBL10018924

SCHEMBL10018924

COc1cc(-c2cc(=O)c3c(OC)cc(OCC#N)cc3o2)ccc1C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.56
MAOB P27338 10/20 0.54
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ABCG2 Q9UNQ0 2/20 0.52
KDM4E B2RXH2 2/20 0.52
NPC1 O15118 1/20 0.52
ALDH1A1 P00352 1/20 0.52
RAB9A P51151 1/20 0.52
BRD4 O60885 1/20 0.52
CSNK2A2 P19784 2/20 0.49
CSNK2B P67870 2/20 0.49
CSNK2A1 P68400 2/20 0.49
MAOA P21397 5/20 0.48
POLH Q9Y253 1/20 0.48
TP53 P04637 1/20 0.48
MDM2 Q00987 1/20 0.48
PPARG P37231 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928629 0.91 ABCB1 (0.59) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL10018925 0.91 CYP1B1 (0.59) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL10018926 0.82 ABCB1 (0.55) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL9928630 0.82 CYP1B1 (0.71) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL2484718 0.81 MAOB (0.70) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL8859633 0.77 MAOB (0.66) ABCB1MAOBMEN1KMT2AABCG2
SCHEMBL7603349 0.76 BRD4 (0.64) ABCB1MAOBMEN1KMT2AABCG2
Tetramethylluteolin SCHEMBL29572571 0.75 ABCB1 (0.80) ABCB1MEN1KMT2AABCG2KDM4E
Tetramethylluteolin SCHEMBL29725288 0.75 ABCB1 (0.80) ABCB1MEN1KMT2AABCG2KDM4E
Tetramethylluteolin SCHEMBL1421511 0.75 ABCB1 (0.80) ABCB1MEN1KMT2AABCG2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8203011-B2 3′,4′,5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same DONG-A PHARM. CO., LTD. (KR) 2012-06-19 US disclosed
US-20100130448-A1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULATN OF MUCUS SECRETION, METHOD FOR THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD (KR) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130448-A1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULATN OF MUCUS SECRETION, METHOD FOR THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME TLR5, PTN, TSLP ABCB1 2160/4885MAOB 3463/4885MEN1 3352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.